ON THE CONTROL OF TUMOR GROWTH VIA TYPE-1 AND INTERVAL TYPE-2 FUZZY LOGIC
暂无分享,去创建一个
Shahrzad Gholami | Aria Alasty | Hassan Salarieh | Mehdi Hosseinian-Sarajehlou | H. Salarieh | A. Alasty | Shahrzad Gholami | Mehdi Hosseinian-Sarajehlou
[1] Robert S. Parker,et al. Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization , 2009, Comput. Chem. Eng..
[2] Paolo Magni,et al. Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.
[3] R. B. Martin,et al. Optimal control drug scheduling of cancer chemotherapy , 1992, Autom..
[4] Dongrui Wu,et al. Comparison and practical implementation of type-reduction algorithms for type-2 fuzzy sets and systems , 2011, 2011 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE 2011).
[5] G. W. Swan. Cancer chemotherapy: Optimal control using the Verhulst-Pearl equation , 1986 .
[6] Oscar Castillo,et al. Handling Uncertainty in Controllers Using Type-2 Fuzzy Logic , 2005, The 14th IEEE International Conference on Fuzzy Systems, 2005. FUZZ '05..
[7] Oscar Montiel,et al. Experimental study of intelligent controllers under uncertainty using type-1 and type-2 fuzzy logic , 2007, Inf. Sci..
[8] N. Aguilar,et al. Neural differential tracking control in cancer model , 2006, 2006 American Control Conference.
[9] John M. Harrold,et al. MODEL-BASED DESIGN OF CANCER CHEMOTHERAPY TREATMENT SCHEDULES , 2005 .
[10] Amir Reza Radmard,et al. Five common cancers in Iran. , 2010, Archives of Iranian medicine.
[11] Ami Radunskaya,et al. A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .
[12] A. Ghaffari,et al. Mathematical Modeling and Lyapunov-Based Drug Administration in Cancer Chemotherapy , 2009 .
[13] A. G. Floares,et al. Adaptive neural networks control of drug dosage regimens in cancer chemotherapy , 2003, Proceedings of the International Joint Conference on Neural Networks, 2003..
[14] Jon Ernstberger,et al. OPTIMAL CONTROL APPLIED TO IMMUNOTHERAPY , 2003 .
[15] Hamid Khaloozadeh,et al. The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB. , 2008, Mathematical biosciences.
[16] Ali Montazeri,et al. Breast Cancer in Iran: An Epidemiological Review , 2007, The breast journal.
[17] Hiok Chai Quek,et al. A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure , 2007, Expert Systems with Applications.
[18] M. MendelJ.. Type-2 Fuzzy Sets and Systems , 2007 .
[19] Raj Jena,et al. Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimation , 2012, Comput. Methods Programs Biomed..
[20] H. Khaloozadeh,et al. Optimal Fuzzy Dosage Programming for Patients Suffering from Breast Cancer in Stage IIB , 2008, 2008 Cairo International Biomedical Engineering Conference.
[21] HR Ramezanpour,et al. A Novel Scheme for Optimal Control of a Nonlinear Delay Differential Equations Model to Determine Effective and Optimal Administrating Chemotherapy Agents in Breast Cancer , 2011, Iranian journal of cancer prevention.
[22] E. Y. K. Ng,et al. Application of K- and Fuzzy c-Means for Color Segmentation of Thermal Infrared Breast Images , 2010, Journal of Medical Systems.